|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.321 USD | -8.29% |
|
-35.30% | -84.34% |
| Apr. 15 | Ampio Pharmaceuticals, Inc.(NYSEAM:AMPE) dropped from S&P TMI Index | CI |
| Mar. 27 | Ampio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Ampio Pharmaceuticals, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 16.34 million compared to USD 17.08 million a year ago. Basic loss per share from continuing operations was USD 21.6 compared to USD 25.8 a year ago.
Diluted loss per share from continuing operations was USD 29.4 compared to USD 30.2 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -84.34% | 364K | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.73B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
AMPIO PHARMACEUTICALS, INC. 
